by in
Entry Author Date Location
Versartis Grabs $21M 02/16/11 San Francisco
Versartis Obtains $21,000,000 Series B Financing Round 02/16/11 San Francisco
$17.6M Debt Round for Spine Wave 02/04/11 Boston
Spine Wave Receives $17,500,000 New Funding Round 02/03/11 Boston
$2M Debt Funding for Stromedix 01/26/11 Boston
Pearl Therapeutics Receives $69,000,000 Series C Financing Round 10/19/10 San Francisco
Relypsa Snags $70M Venture Round to Get Rid of Excess Potassium in Blood 09/13/10 San Francisco
Relypsa Obtains $70,000,000 Series B Funding 09/13/10 San Francisco
Altura Medical Obtains $20,000,000 Series A Round 06/02/10 San Diego
Aviir Lands $4,200,000 New Financing Round 03/31/10 San Francisco
Aureon Biosciences Receives $7,000,000 New Funding Round 03/19/10 New York
Marathon and Zafgen Add to Series B Rounds, Athenahealth and Sermo Announce Partnership, Sensata Sets IPO Terms, & More Boston-Area Deals News 03/03/10 Boston
Intrinsic Therapeutics Grabs $18M 02/26/10 Boston
Intrinsic Therapeutics Obtains $18,000,000 New Funding Round 02/26/10 Boston
San Diego’s Tioga Pharmaceuticals Raises $18 Million to Develop IBS Drug 02/17/10 San Diego
Tioga Pharmaceuticals Secures $18,000,000 New Funding Round 02/17/10 San Diego
Pearl Therapeutics Garners $15,000,000 Series C Round 02/01/10 San Francisco
Afferent Pharmaceuticals Receives $23,000,000 Series A Round 12/16/09 Boston
HubSpot Spots $16M, Synageva BioPharma Secures $12M, Currensee Sews Up $6M, & More Boston-Area Deals News 10/23/09 Boston
Flexion Pulls in $33M, Cubist Teams With Hydra, Charles River Makes Cuts, & More Boston-Area Life Sciences News 10/21/09 Boston
Synageva BioPharma Corp Receives $12,000,000 Series F Financing Round 10/21/09 Boston
Synageva Finishes $45M Round 10/20/09 Boston
Synageva BioPharma Corp Lands $12,000,000 New Financing Round 10/20/09 Boston
Direct Flow Medical Lands $40,000,000 Series C Financing 10/04/09 San Francisco
New England Venture Activity Rebounds Slightly in Q2—Region’s Top 10 Deals List 07/21/09 Boston
Presidio Pharmaceuticals Secures $27,000,000 Series B Financing 07/10/09 San Francisco
Merck and Roche Back Adimab, Viral Contamination Closes Genzyme Plant, Interlace Ties on $20.5M, & More Boston-Area Life Sciences News 06/17/09 Boston
Interlace Sews Up $20.5M Series C Round 06/15/09 Boston
Interlace Medical Inc Obtains $20,500,000 Series C Funding Round 06/15/09 Boston
Visiogen, Inc. Garners $40,000,000 New Funding Round 04/27/09 San Diego
Page 2 of 3 « previous page · next page »